# Epilepsy Gene Variant Analysis

Comprehensive variant analysis reports for five epilepsy-related genes based on ClinVar database and published literature.

**Live Site:** [https://ykshim2013.github.io/Epilepsy_phenotype/](https://ykshim2013.github.io/Epilepsy_phenotype/)

---

## Gene Report Pages

| Gene | Page URL | QR Code |
|------|----------|---------|
| **Home** | [https://ykshim2013.github.io/Epilepsy_phenotype/](https://ykshim2013.github.io/Epilepsy_phenotype/) | ![Home QR](https://api.qrserver.com/v1/create-qr-code/?size=100x100&data=https://ykshim2013.github.io/Epilepsy_phenotype/) |
| **SCN2A** | [https://ykshim2013.github.io/Epilepsy_phenotype/SCN2A_variant_analysis](https://ykshim2013.github.io/Epilepsy_phenotype/SCN2A_variant_analysis) | ![SCN2A QR](https://api.qrserver.com/v1/create-qr-code/?size=100x100&data=https://ykshim2013.github.io/Epilepsy_phenotype/SCN2A_variant_analysis) |
| **EEF1A2** | [https://ykshim2013.github.io/Epilepsy_phenotype/EEF1A2_variant_analysis](https://ykshim2013.github.io/Epilepsy_phenotype/EEF1A2_variant_analysis) | ![EEF1A2 QR](https://api.qrserver.com/v1/create-qr-code/?size=100x100&data=https://ykshim2013.github.io/Epilepsy_phenotype/EEF1A2_variant_analysis) |
| **KCNQ2** | [https://ykshim2013.github.io/Epilepsy_phenotype/KCNQ2_variant_analysis](https://ykshim2013.github.io/Epilepsy_phenotype/KCNQ2_variant_analysis) | ![KCNQ2 QR](https://api.qrserver.com/v1/create-qr-code/?size=100x100&data=https://ykshim2013.github.io/Epilepsy_phenotype/KCNQ2_variant_analysis) |
| **SYNGAP1** | [https://ykshim2013.github.io/Epilepsy_phenotype/SYNGAP1_variant_analysis](https://ykshim2013.github.io/Epilepsy_phenotype/SYNGAP1_variant_analysis) | ![SYNGAP1 QR](https://api.qrserver.com/v1/create-qr-code/?size=100x100&data=https://ykshim2013.github.io/Epilepsy_phenotype/SYNGAP1_variant_analysis) |
| **CDKL5** | [https://ykshim2013.github.io/Epilepsy_phenotype/CDKL5_variant_analysis](https://ykshim2013.github.io/Epilepsy_phenotype/CDKL5_variant_analysis) | ![CDKL5 QR](https://api.qrserver.com/v1/create-qr-code/?size=100x100&data=https://ykshim2013.github.io/Epilepsy_phenotype/CDKL5_variant_analysis) |

---

## Summary Statistics

| Gene | P | LP | P/LP* | Unique P/LP | Total ClinVar | Key Phenotype |
|------|---|----|----|-------------|---------------|---------------|
| SCN2A | 437 | 361 | 56 | **742** | 2,978 | DEE11, BFNIS |
| EEF1A2 | 69 | 45 | 7 | **107** | 728 | DEE33 |
| KCNQ2 | 621 | 332 | 196 | **757** | 2,493 | BFNS, KCNQ2-DEE |
| SYNGAP1 | 323 | 129 | 22 | **430** | 1,833 | MRD5, SYNGAP1-DEE |
| CDKL5 | 763 | 306 | 68 | **1,001** | 2,407 | CDD, DEE2 |

*P/LP = Variants with both Pathogenic and Likely Pathogenic submissions. Unique P/LP = P + LP - P/LP (to avoid double-counting).

---

## Report Structure

Each gene report includes:

1. **Overall Summary (전체)** - Total variant counts, publications, patient numbers
2. **ClinVar P/LP** - Pathogenic and Likely Pathogenic variants
3. **Non-P/LP Variants** - VUS, Benign, and literature-only variants
4. **Korean Patient Data** - Korean-specific publications and variants
5. **Phenotype Review** - Onset age, responsive ASMs, syndrome classification

---

## Quick Reference: Treatment by Gene

| Gene | First-Line ASM | Notes |
|------|----------------|-------|
| **SCN2A** | Na+ channel blockers (if onset <3mo) | GOF vs LOF determines treatment |
| **EEF1A2** | Variable | Generally drug-resistant |
| **KCNQ2** | Carbamazepine, Phenytoin | ~80% respond to Na+ blockers |
| **SYNGAP1** | Valproate, Lamotrigine | CBD promising |
| **CDKL5** | Vigabatrin | Only 24% maintain response at 12mo |

---

## Data Sources

- [ClinVar Database](https://www.ncbi.nlm.nih.gov/clinvar/)
- [PubMed Literature](https://pubmed.ncbi.nlm.nih.gov/)
- [GeneReviews](https://www.ncbi.nlm.nih.gov/books/NBK1116/)

---

## License

This project is for educational and research purposes.

---

*Data accessed January 2026. Variant counts and classifications are subject to change as databases are updated.*
